Oncology Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others), By Nutrition (Enteral Nutrition, Parenteral Nutrition), By Formula (Standard Formula, Elemental Formula, Specialized Formula), By Formula (Hosp
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationOncology Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others), By Nutrition (Enteral Nutrition, Parenteral Nutrition), By Formula (Standard Formula, Elemental Formula, Specialized Formula), By Formula (Hosp
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 2.14 billion |
| CAGR (2023-2028) | 8.41% |
| Fastest Growing Segment | Enteral Nutrition |
| Largest Market | North America |
Market Overview
Key Market Drivers
Rising Cancer Incidence
Nutritional Challenges in Cancer Patients
Advancements in Medical Research
Market Innovation
Key Market Challenges
Regulatory Hurdles
Treatment-Related Side Effects
Patient Compliance
Cost Constraints
Key Market Trends
Nutrigenomics
Digital Health Solutions
Functional Foods and Nutraceuticals
Sustainable and Ethical Nutrition
Segmental Insights
Cancer Type Insights
End User Insights
Regional Insights
Recent Developments
- In July 2022, Nestle introduced China's inaugural Foods for SpecialMedical Purpose (FSMP) designed for patients dealing with tumor-relatedconditions. This achievement came after a rigorous five-year approval processwith Chinese regulatory authorities.
- In January 2022, Faeth Therapeutics successfully concluded a Series Afunding round, securing USD 47 million in private financing, with S2G Venturesas the lead investor. This funding round brought their total capital raised toUSD 67 million thus far. The proceeds from this financing will be allocatedtowards advancing Faeth's clinical trials, which employ a combination ofnutrient management, pharmaceuticals, and digital tools to inhibit the growthof cancer.
Key Market Players
- Abbott Laboratories Inc
- NestleSA
- FreseniusKabi AG
- BBraun SE
- HormelFoods Corporation
- DanoneSA
- MEIJIHoldings Co Ltd
- GlobalHealth Products, Inc.
- VictusInc
- MeadJohnson & Co LLC
| By Cancer Type | By Nutrition | By Formula | By Distribution Channel | By End User | By Region |
|
|
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy